However, the improved tumor penetration of anti-PD-1 antibody was compromised in Bati-pretreated Met@Man-MPs group, revealing that the tumor penetration of anti-PD-1 antibody was achieved by the Met@Man-MPs-induced collagen degradation in tumor tissues. The gene discussed is PDCD1; the disease is neoplasm.